Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Aug 18, 2010
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Type 2 DM
- • 2. Hypercholesterolemia (baseline screening LDL-C \> 100 mg/dL)
- • 3. In case of medication, stable doses of oral hypoglycemic agents for at least three months
- • 4. HbA1c \<8.5%
- • 5. Age: 20-80
- Exclusion Criteria:
- • 1. Chronic renal failure: creatinine \> 3.0 mg/dL
- • 2. Serious liver disease (\> x3 LFT UNL)
- • 3. Congestive heart failure
- • 4. Stroke or MI/coronary intervention during the preceding 3 months.
- • 5. CK \> x 2.5 UNL
- • 6. Unstable hypo/hyperthyroidism
- • 7. Pregnant/lactating woman, or woman intending to become pregnant
- • 8. Subject with any clinically significant condition or situation, in the opinion of the investigator, would interfere with the study evaluations or optimal participation in the study.
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials